[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:transthyretin-related-familial-amyloid-cardiomyopathy":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":63,"states":64},"Transthyretin related familial amyloid cardiomyopathy",8,5,[8,16,23,29,35,41,48,55],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07207811","CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis",[12],"Phase 3","RECRUITING","2026-08-26T02:15:41.377360Z","2026-07-05T05:32:16.662639Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07695701","Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis",[20],"Phase 4","2026-08-26T02:16:09.452956Z","2026-07-30T01:46:14.443612Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07196839","Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study",[],"2026-08-26T02:17:41.695983Z","2026-05-13T02:55:06.670964Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07215715","US Benchmarking Clinical Study",[],"2026-08-26T02:16:26.411851Z","2026-05-13T02:55:06.677367Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06539169","FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases",[],"2026-08-26T02:18:44.395098Z","2026-05-13T02:55:06.551987Z",{"nct_id":42,"title":43,"phases":44,"status":45,"updated_at":46,"content_modified":47},"NCT07690436","Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM",[],"NOT_YET_RECRUITING","2026-08-26T02:16:42.787115Z","2026-07-19T19:36:05.153114Z",{"nct_id":49,"title":50,"phases":51,"status":52,"updated_at":53,"content_modified":54},"NCT07398950","Prospective Evaluation of Artificial Intelligence-enabled Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:20.225313Z","2026-05-13T02:55:06.701126Z",{"nct_id":56,"title":57,"phases":58,"status":60,"updated_at":61,"content_modified":62},"NCT07608354","A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM.",[59],"Phase 2","ACTIVE_NOT_RECRUITING","2026-08-03T02:47:42.534177Z","2026-05-29T15:36:40.226451Z",[],[65,69,72,76,79,82,85],{"state":66,"count":67,"slug":68},"California",4,"california",{"state":70,"count":67,"slug":71},"Massachusetts","massachusetts",{"state":73,"count":74,"slug":75},"Illinois",3,"illinois",{"state":77,"count":74,"slug":78},"Missouri","missouri",{"state":80,"count":74,"slug":81},"Oregon","oregon",{"state":83,"count":74,"slug":84},"Tennessee","tennessee",{"state":86,"count":74,"slug":87},"Texas","texas"]